| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |